Lunai Bioworks Inc. — Form SCHEDULE 13D/A
Filed October 15, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Form Schedule 13D/A (amended beneficial ownership statement) was filed on 2026-10-15 by William Anderson Wittekind regarding Lunai Bioworks Inc. The filing document itself contains no substantive disclosure of ownership percentage, share count, acquisition details, or material changes to beneficial ownership position. The raw filing metadata only lists addresses and basic identifiers without the actual amended Item 4-5 disclosures required.
Why this rating
Cannot assess materiality without actual ownership %, share counts, or transaction details. Boilerplate filing header only; no substance disclosed to evaluate business impact.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.